0000899243-18-022575.txt : 20180816 0000899243-18-022575.hdr.sgml : 20180816 20180816170048 ACCESSION NUMBER: 0000899243-18-022575 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180814 FILED AS OF DATE: 20180816 DATE AS OF CHANGE: 20180816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Watson W. Mark CENTRAL INDEX KEY: 0001612372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 181023865 MAIL ADDRESS: STREET 1: 324 S. HYDE PARK AVENUE STREET 2: STE 350 CITY: TAMPA STATE: FL ZIP: 33606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-14 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0001612372 Watson W. Mark C/O BIODELIVERY SCIENCES INTL, INC. 4131 PARKLAKE AVE. SUITE 225 RALEIGH NC 27612 1 0 0 0 Common Stock 2018-08-14 4 M 0 9740 0.00 A 11240 D Restricted Stock Units 0.00 2018-08-14 4 M 0 9740 0.00 D 2022-08-01 Common Stock 9740 99379 D The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units ("RSUs") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs vest as follows: (i) 24,379 RSUs vest in the first open window following the Company's 2019 Annual Meeting of Stockholders, (ii) 30,000 RSUs vest in the first open window following the Company's 2020 Annual Meeting of Stockholders, (iii) 30,000 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (iv) 15,000 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders. /s/ William Mark Watson 2018-08-16